178 related articles for article (PubMed ID: 38569270)
1. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
Hayee R; Iqtedar M; Albekairi NA; Alshammari A; Makhdoom MA; Islam M; Ahmed N; Rasool MF; Li C; Saeed H
J Infect Public Health; 2024 May; 17(5):906-917. PubMed ID: 38569270
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles.
Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J
Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983
[TBL] [Abstract][Full Text] [Related]
4. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
5. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
[TBL] [Abstract][Full Text] [Related]
6. Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol.
Miele D; Catenacci L; Sorrenti M; Rossi S; Sandri G; Malavasi L; Dacarro G; Ferrari F; Bonferoni MC
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480614
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
Pandit J; Sultana Y; Aqil M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
[TBL] [Abstract][Full Text] [Related]
8. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.
Kashi TS; Eskandarion S; Esfandyari-Manesh M; Marashi SM; Samadi N; Fatemi SM; Atyabi F; Eshraghi S; Dinarvand R
Int J Nanomedicine; 2012; 7():221-34. PubMed ID: 22275837
[TBL] [Abstract][Full Text] [Related]
9. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S
Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
15. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
16. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.
Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S
AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983
[TBL] [Abstract][Full Text] [Related]
18. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
Li Z; Xiong F; He J; Dai X; Wang G
Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
[TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
Shaaban MI; Shaker MA; Mady FM
J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
